Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000671

Drug Information
SynonymsPentabarbitone; UNII-I4744080IR; DivK1c_000992; AC1L1IUE; D00499; Pentobarbitalum; Pentobarbital [USP:INN]; Spectrum5_001705; BSPBio_003305; 5-24-09-00168 (Beilstein Handbook Reference); Pentobarbital (USP/INN); Pentabarbital; Mebubarbital; Pentobarbital suppository dosage form; Pentobarbitale [DCIT]; Spectrum4_000574; HSDB 3151; Pentobarbitone; Etaminal; 5-Ethyl-5-(1-methylbutyl)malonylurea; (+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid; KBio2_004834; KBio3_002807; Spectrum2_001991; CHEMBL448; 57-33-0 (mono-hydrochloride salt); Mebumal; KBioSS_002267; Neodorm (new); Oprea1_143902; Pentobarbital (VAN); Spectrum3_001783; Pentobarbiturate; KBio2_007402; HMS2094E21; LS-24385; SPECTRUM1900006; Ethaminal; Pentobarbitale; NINDS_000992; WLN: T6VMVMV FHJ FY3&1 F2; 5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione; 5-Ethyl-5-(sec-pentyl)barbituric acid; NCGC00096074-01; MolPort-001-785-697; CCRIS 7089; SPBio_002201; C07422; 76-74-4; KBioGR_001008; Barbituric acid, 5-ethyl-5-(1-methylbutyl)-; CHEBI:7983; Nebralin; DEA No. 2270; Nembutal (TN); 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+-)-; Pentobarbitalum [INN-Latin]; Neodorm; 5-Ethyl-5-(1-methylbutyl)barbituric acid; Spectrum_001783; 5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione; IDI1_000992; Nembutal (VAN); AKOS000277861; Aethaminalum; MolPort-003-666-760; NSC 28708; KBio1_000992; Dorsital; HMS503G05; 5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione; Pentobarbital calcium; Ethyl-propylmethylcarbinylbarbituric acid; Pentobarbituric acid; DB00312; Neodorm (VAN); Rivadorm; EINECS 200-983-8; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-; Pentobarbital, Monosodium Salt; BRN 0087067; pentobarbital; KBio2_002266; AC1Q2UJM; Barbituric acid, 5-ethyl-5-(2-pentyl)-; NCGC00096074-02; Oprea1_775730; CID4737; 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; Pentobarbitone (VAN); NSC28708; Nembutal
Trade NameNembutal
[ICD9: 307.41, 307.42, 327.0, 780.51, 780.52   ICD10: F51.0, G47.0]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCCCC(C)C1(C(=O)NC(=O)NC1=O)CC    
Therapeutic ClassHypnotics and Sedatives
CAS NumberCAS 76-74-4
PubChem Compound IDCID 4737.
PubChem Substance IDSID 9626.
SuperDrug ATC IDN05CA01
SuperDrug CAS ID000076744;
TargetGamma-aminobutyric acid receptor subunit alpha-1Antagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 083270 To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543